Glucose-dependent Insulinotropic Polypeptide Receptor Agonist
- Name
- Glucose-dependent Insulinotropic Polypeptide Receptor Agonist
- Accession Number
- DBCAT005844
- Description
Not Available
- Drugs
Drug Drug Description Tirzepatide A dual GIP and GLP-1 receptor agonist used for the treatment of type II diabetes in adults as an adjunct to diet and exercise. - Drugs & Drug Targets
Drug Target Type Tirzepatide Glucagon-like peptide 1 receptor target Tirzepatide Gastric inhibitory polypeptide target Tirzepatide Serum albumin carrier